Trials / Completed
CompletedNCT05446909
Preventing Cognitive Decline
Modulation Effects of a Novel Body-mind Intervention on Subjective Cognitive Decline
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Arizona State University · Academic / Other
- Sex
- All
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The study aims to understand the mechanisms and training effects of evidence-based body-mind training on improving cognitive performance and preventing cognitive decline.
Detailed description
Subjective cognitive decline (SCD), the self-reported perception of memory or cognitive problems, is a risk factor for the cognitive decline and development of Alzheimer's (AD) and often happens in midlife. Recently, few mind-body interventions have suggested promising effects in preventing cognitive decline. However, these interventions often require longer training time (months to years) to achieve modest benefits, making them less optimal for rapidly learning and achieving desirable outcomes. One mechanism for cognitive decline and AD may involve deficits in self-control networks, and autonomic nervous system (ANS) and these deficits can be ameliorated through body-mind interventions. This study aims to investigate the modulation effects of a novel body-mind intervention on SCD using an evidence-based preventive intervention - integrative body-mind training (IBMT).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | IBMT mindfulness | IBMT is an effortless mindfulness technique; health education is a class including health-related topics - exercise, sleep, nutrition, lifestyle, stress management |
| BEHAVIORAL | health education | Health education includes health-related topics - exercise, sleep, stress management, nutrition, lifestyle |
Timeline
- Start date
- 2021-02-01
- Primary completion
- 2023-02-28
- Completion
- 2023-02-28
- First posted
- 2022-07-07
- Last updated
- 2024-10-29
- Results posted
- 2024-10-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05446909. Inclusion in this directory is not an endorsement.